XML 65 R53.htm IDEA: XBRL DOCUMENT v3.25.4
Business Combinations - Summary of reconciliation of cash flows included in investing activities (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2025
USD ($)
Statement of Cash Flows [Abstract]  
Acquisition of scPharma, net of cash acquired $ 347,742
Issuance of note receivable 10,000
Total included in cash flows from investing activities 357,742
Contingent consideration liability 25,217
Cash aquired in acquisition of scPharma 38,679
Total purchase price $ 421,638